Disc Medicine, Inc.
IRON
$59.79
$0.821.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.48% | -24.93% | -88.35% | -65.25% | -18.30% |
| Total Depreciation and Amortization | -23.08% | -64.00% | -56.00% | 340.00% | 4.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.71% | 341.90% | 38.60% | 27.56% | 279.06% |
| Change in Net Operating Assets | -5.56% | -109.54% | 39.55% | 2,024.48% | 21.29% |
| Cash from Operations | -23.15% | -54.94% | -132.22% | -20.98% | 5.26% |
| Capital Expenditure | -1,170.15% | -14,866.67% | 117.78% | 125.00% | -131.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -406,814.93% | -47,433.33% | -157,877.78% | -1,831,141.67% | -131.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,377.14% | -84.51% | -17.76% | 19.87% | -67.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,436.17% | 271.19% | -7.39% | 12.57% | -79.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -292.65% | 97.99% | -1,146.64% | -143.90% | -142.49% |